Scarica l'app Stockscreener
9.42
3.29%
0.30
Dopo l'orario di chiusura:
9.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.12
Aprire:
$9.27
Volume 24 ore:
795.17K
Relative Volume:
1.04
Capitalizzazione di mercato:
$734.17M
Reddito:
$1.64B
Utile/perdita netta:
$-516.47M
Rapporto P/E:
-1.3987
EPS:
-6.7348
Flusso di cassa netto:
$-45.25M
1 W Prestazione:
-1.26%
1M Prestazione:
-17.22%
6M Prestazione:
-34.26%
1 anno Prestazione:
-57.16%
Intervallo 1D:
$8.87
$9.455
Intervallo di 1 settimana:
$8.87
$9.909
Portata 52W:
$8.70
$21.95
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
9.42 | 710.79M | 1.64B | -516.47M | -45.25M | -6.7348 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
Macro Review: Can Integra LifeSciences Holdings Corporation weather a recession2026 Retail Activity & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
IPO Launch: Can Integra LifeSciences Holdings Corporation deliver consistent dividends2026 Pullback Review & Accurate Buy Signal Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Vanguard disaggregates holdings; reports zero ownership in Integra (IART) - Stock Titan
IART SEC FilingsIntegra Lifesciences Hldgs Cp 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Momentum: What is the earnings history of Integra LifeSciences Holdings CorporationRate Hike & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Risk Analysis: Can Integra LifeSciences Holdings Corporation generate free cash flowMarket Growth Summary & Long-Term Growth Plans - baoquankhu1.vn
Integra LifeSciences (NASDAQ:IART) Market Dynamics Track Nasdaq Index - Kalkine Media
Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance
Integra Lifesciences (IART) EVP reports major RSU grant and vesting - Stock Titan
Integra (IART) EVP receives 92,108 RSUs and surrenders shares for taxes - Stock Titan
Integra (NASDAQ: IART) EVP gets 43,350 RSUs, shares withheld for tax - Stock Titan
Integra Lifesciences (IART) SVP granted 15,957 RSUs with 1,147 shares withheld for taxes - Stock Titan
Integra (IART) CFO granted 111,179 RSUs; 8,089 shares withheld for tax - Stock Titan
Integra Lifesciences (IART) EVP gets 41,783 RSUs, 5,420 shares for tax - Stock Titan
Integra (IART) CEO granted 343,393 restricted stock units as deferred pay - Stock Titan
Integra Lifesciences (IART) CLO granted 70,305 restricted stock units - Stock Titan
Citigroup Maintains Sell Rating on IART and Lowers Price Target - GuruFocus
IART (Integra Lifesciences Holdings) NonCurrent Deferred Re - GuruFocus
IART Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Integra LifeSciences (NASDAQ:IART) Downgraded to “Hold” Rating by Wall Street Zen - Defense World
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings is Now Oversold (IART) - Nasdaq
Integra LifeSciences Holdings Corp. Sees Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
IART Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Integra LifeSciences Hits 52-Week Low at $10.36 Amidst Ongoing Struggles - Markets Mojo
Integra LifeSciences Opens Weak with 8.37% Gap Down Amid Market Concerns - Markets Mojo
Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.7% Following Analyst Downgrade - MarketBeat
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Integra Lifesciences (IART) Analyst Rating Update: Wells Fargo L - GuruFocus
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - MarketBeat
US med-tech companies bullish about 2026 - BioWorld MedTech
Stocks making big moves this week: Flywire, First Advantage, Integra LifeSciences, Huron, and Montrose - Yahoo Finance
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month LowWhat's Next? - MarketBeat
Integra Lifesciences Holdings Corp (IART) Q4 2025 Earnings Call - GuruFocus
Integra LifeSciences Q4 Earnings Call Highlights - Yahoo Finance
Integra LifeSciences (IART) Stock Trades Down, Here Is Why - Finviz
Integra LifeSciences (NASDAQ:IART) Shares Gap DownWhat's Next? - MarketBeat
Earnings call transcript: Integra LifeSciences beats Q4 2025 EPS forecast - Investing.com
Integra LifeSciences (NASDAQ:IART) Surprises With Q4 CY2025 Sales - Finviz
Q4 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Q4 25 Earnings Conference Call At 8:30 AM ET - Nasdaq
Integra LifeSciences (IART) Projects 2026 Revenue Growth - gurufocus.com
INTEGRA LIFESCIENCES HLDGS ($IART) Releases Q4 2025 Earnings - Quiver Quantitative
Integra LifeSciences beats estimates but guides below consensus By Investing.com - Investing.com South Africa
Integra LifeSciences beats estimates but guides below consensus - Investing.com
Integra: Q4 Earnings Snapshot - marketscreener.com
Integra LifeSciences Reports Q4 Loss, Revenue Edges Down - Nasdaq
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Integra Lifesciences Holdings Corp Azioni (IART) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):